4//SEC Filing
Shah Nikita 4
Accession 0001628280-25-052413
CIK 0001723128other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:13 PM ET
Size
11.9 KB
Accession
0001628280-25-052413
Insider Transaction Report
Form 4
Shah Nikita
Executive Vice President
Transactions
- Exercise/Conversion
Class A Common Stock
2025-11-12$2.75/sh+95,525$262,694→ 278,259 total - Sale
Class A Common Stock
2025-11-12$11.92/sh−131,856$1,571,724→ 146,403 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-12−36,331→ 0 totalExercise: $2.75Exp: 2028-05-07→ Class A Common Stock (36,331 underlying) - Exercise/Conversion
Class A Common Stock
2025-11-12$2.75/sh+36,331$99,910→ 182,734 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-12−95,525→ 0 totalExercise: $2.75Exp: 2029-03-01→ Class A Common Stock (95,525 underlying)
Footnotes (2)
- [F1]The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.85 to $12.02 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]This option is fully vested.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001738061
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 5:13 PM ET
- Size
- 11.9 KB